DERM vs TLRY · rev $34.5M vs rev $915.5M
Journey Medical Corp (DERM) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
DERM currently screens at market cap $163.1M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the DERM and TLRY stock pages for the full models.
Not investment advice.